Peer Review History
| Original SubmissionMarch 28, 2024 |
|---|
|
Dear Dr. Balmant, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 23 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Tzen-Yuh Chiang Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in the Acknowledgments Section of your manuscript: "We thank Christopher Dervinis for his advice and insightful discussions throughout the course of this study. Funding was provided by USDA NIFA SCRI (Grant No. 2018-51181-28419 and 2022-51181-38333)." We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "MFRR USDA NIFA SCRI Grant No. 2018-51181-28419 and 2022-51181-38333 United States Department of Agriculture National Institute of Food and Agriculture Specialty Crop Research Initiative https://www.nifa.usda.gov/grants/funding-opportunities/specialty-crop-research-initiative The the sponsors or funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript" Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 3. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: No ********** Reviewer #1: Please see the attached PDF for my full review comments. Also, I did not find the link to access any of the data; it is not found in the github repository either. Please check whether you have included it in the manuscript. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Dear Dr. Balmant, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Apr 04 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Tzen-Yuh Chiang Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: Partly Reviewer #3: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: No Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: No Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #2: In a revised manuscript to PLoS One, Madrid and colleagues present their findings regarding a DAPI+/Chlorophyll- sorting strategy for nuclei prior to 10x genomics microfluidic library preparation. Using this strategy the authors convincingly show depletion of autofluorescence (presumed to be chlorophyll), depletion of cpDNA, and marked atpA and psbA demonstrated independently by qPCR. In response to the first round of reviews, of which I read but was not involved, the authors appear to have added descriptive statistics to their results and several language changes suggested by previous reviewers. In my reading of this, my opinion is that the findings are meaningful but could benefit from more precise language especially pertaining to how the presence of chlorophyll and/or ambient RNA could impact the results when present. Major concerns/comments: 1. The strongest data in this manuscript appears to be the removal of cpDNA and the qPCR data regarding atpA and psbA. I find this sufficient as is, but disconnected from mentions of statistical power, identification of cell type identity, or any other snRNAseq applications. Are there specific applications for performing snRNAseq that are disrupted by chlorophyll presence (diff expression, a cell type that is depleted, any other analysis)? Without demonstrating that the DAPI+/autoflu- fixes that, the only improvement that I understand is increased reads mapping to genome (which I would note is low even in the improved condition). 2. The observations appear to be made from running 2 samples (one from cell suspension without FACS and one with FACS “double” meaning “DAPI+/autoflu-“ is that the case? The authors do a fine job reporting QC statistics, but including sample size and replicates are necessary to making claims that this is a “novel sorting strategy” that others should employ. 3. I am unable to assess the rigor of data analysis as the data nor the scripts were made accessible to me. Github link points to an account, but the accompanying code for this manuscript was not obvious to find. Please update along with GEO or other database references. Minor concerns/comments: • In “computational workflow for scRNAseq data analysis” on line 197, how many barcodes/nuclei were removed with the <0.2% plastid percentage? Were less removed from the FACS filtered? This would be critical evidence to the authors points. Same question for the 0.5% chloroplast perentage in line 214 under “Generation of quality metrics”. • Descriptions of ambient RNA were made however, there are several existing packages that could predict presence of ambient RNA and report statistics to help the author’s points. It would be of interest if these algorithms predict higher ambient RNA in non-FACS sample(s) compared to FACS. Reviewer #3: Gabriela Madrid and colleagues developed a very efficient protocol to remove chloroplasts from leaf tissue of plant during the snRNA-seq experiment. They set up a new method of applying double filters strategy which first negatively select autofluorescent chloroplast and then positively select DAPI stained nuclei, thus achieving a relatively purified nuclei and snRNA-seq data. While I appreciate the value of this research, I think there are some aspects of this manuscript need to be further polished and more analysis should be done to deliver a more solid conclusion: 1. Line 47, it is a little bit confusing to me to say "The success of scRNA-seq is dependent on the acquisition of high-quality datasets." As a researcher most working on wet-lab experiment, the aim of scRNA-seq experiment, at least to myself, is to obtain high quality data. It is a little bit weird to say "the success of scRNA-seq depends on acquiring high quality datasets." Sounds like attributing result as reason. 2. Line 82-84, "For droplet-based methods, where the individual cells or nuclei are captured in microfluidic droplets containing the reagents for library preparation, it is assumed that each droplet contains only RNA from an intact single cell." It would be more precise to add "or nucleus" at the end of this sentence. 3. Line 152, it should be "double filters" or "double-filter" strategy. 4. Figure 3A, previous introduction mentioned that DAPI could also stain chloroplasts causing contaminations during FACS sorting. But in this experiment, there is no obvious clue that chloroplasts are also stained by DAPI. Need more discussion to explain the reason of the difference between FACS and microscope experiment. 5. Line 373-377, the qPCR result of atpA and psbA from extracting RNA with different purification strategies, I think it would be better to put this experiment and data in the first two figures, that demonstrates the effectiveness of double filters strategy with a relatively simple but less comprehensive way. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: Yes: Dominic J. Acri Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 2 |
|
An improved nuclei isolation protocol from leaf tissue for single-cell transcriptomics PONE-D-24-12593R2 Dear Dr. Balmant, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Tzen-Yuh Chiang Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: Yes ********** Reviewer #2: Upon reviewing the responses to reviewers, it is my opinion that the authors provided not only sufficient but extremely convincing answers to all concerns (from both reviewers). The GitHub repo "Madrid_etal_2025" listed in the response to reviewers was not made public so I am unable to review what I asked for, however the authors responses and intent to make it public should be sufficient for publication in this journal. Lastly, cost is not a sufficient justification for sample size. I recognize it is a limitation so do not feel strongly that the authors need to change any their current manuscript. We can agree to disagree on the use of statistics for single cell as the field has not reached a consensus. Furthermore, the FACS experiments are appropriately powered and convincing that the tech introduced by this manuscript represents a meaningful contribution to the field at large. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-24-12593R2 PLOS ONE Dear Dr. Balmant, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Tzen-Yuh Chiang Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .